{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:56:03Z","timestamp":1781510163599,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.msard.2025.106932","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:37:42Z","timestamp":1765669062000},"page":"106932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Relapse activity during pregnancy and the postpartum year is associated with accelerated disability progression in multiple sclerosis"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9938-1435","authenticated-orcid":false,"given":"Lea I","family":"Walter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Kana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"H\u00f6sli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Nierobisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Herwerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2025.106932_bib0001","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000959","article-title":"Clinical and radiologic disease activity in pregnancy and postpartum in MS","volume":"8","author":"Anderson","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"10.1016\/j.msard.2025.106932_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102279","article-title":"The ocrelizumab phase II extension trial suggests the potential to improve the risk: benefit balance in multiple sclerosis","volume":"44","author":"Baker","year":"2020","journal-title":"Mult. Scler. Relat. Disord"},{"issue":"7_Supplement_1","key":"10.1016\/j.msard.2025.106932_bib0003","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1212\/WNL.0000000000211193","article-title":"Placental and breastmilk transfer of Ocrelizumab from women with multiple sclerosis to infants and the potential impact on B-cell levels: primary analysis of the prospective, multicenter, open-label, phase IV studies MINORE and SOPRANINO (PL4.004)","volume":"104","author":"Bove","year":"2025","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2025.106932_bib0004","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1352458518816614","article-title":"Pregnancy and multiple sclerosis in the DMT era: a cohort study in Western Austria","volume":"26","author":"Bsteh","year":"2020","journal-title":"Mult. Scler"},{"issue":"5","key":"10.1016\/j.msard.2025.106932_bib0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple sclerosis group","volume":"339","author":"Confavreux","year":"1998","journal-title":"N. Engl. J. Med"},{"issue":"22","key":"10.1016\/j.msard.2025.106932_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11226643","article-title":"Disease activity and progression in multiple sclerosis: new evidences and future perspectives","volume":"11","author":"Del Negro","year":"2022","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.msard.2025.106932_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2025.2550","article-title":"Therapeutic management during pregnancy and relapse risk in women with multiple sclerosis","author":"Gavoille","year":"2025","journal-title":"JAMA. Neurol"},{"issue":"3","key":"10.1016\/j.msard.2025.106932_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ctn8030026","article-title":"Recommendations for the treatment of multiple sclerosis in Family planning, pregnancy and lactation in Switzerland: immunotherapy","volume":"8","author":"Graber","year":"2024","journal-title":"Clin. Transl. Neurosci"},{"issue":"1","key":"10.1016\/j.msard.2025.106932_bib0009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1756285608100416","article-title":"Immunomodulation and postpartum relapses in patients with multiple sclerosis","volume":"2","author":"Hellwig","year":"2009","journal-title":"Ther. Adv. Neurol. Disord"},{"issue":"1","key":"10.1016\/j.msard.2025.106932_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44750","article-title":"Multiple sclerosis disease activity and disability following discontinuation of Natalizumab for pregnancy","volume":"5","author":"Hellwig","year":"2022","journal-title":"JAMA. Netw. Open"},{"issue":"4","key":"10.1016\/j.msard.2025.106932_bib0011","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200110","article-title":"Multiple sclerosis disease activity and disability following cessation of Fingolimod for pregnancy","volume":"10","author":"Hellwig","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"10.1016\/j.msard.2025.106932_bib0012","author":"Hemmer"},{"issue":"6","key":"10.1016\/j.msard.2025.106932_bib0013","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000890","article-title":"MRI activity in MS and completed pregnancy: data from a tertiary academic center","volume":"7","author":"Houtchens","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"10.1016\/j.msard.2025.106932_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102541","article-title":"Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: data from an administrative claims database","volume":"46","author":"Houtchens","year":"2020","journal-title":"Mult. Scler. Relat. Disord"},{"key":"10.1016\/j.msard.2025.106932_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103391","article-title":"Is pregnancy in MS patients safe and what is its impact on MS course? Real world evidence of 1533 pregnancies in Czech Republic","volume":"59","author":"Hradilek","year":"2022","journal-title":"Mult. Scler. Relat. Disord"},{"issue":"2","key":"10.1016\/j.msard.2025.106932_bib0016","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00415-023-11943-4","article-title":"Ocrelizumab exposure in relapsing-remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension","volume":"271","author":"Kappos","year":"2024","journal-title":"J. Neurol"},{"issue":"9","key":"10.1016\/j.msard.2025.106932_bib0017","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA. Neurol"},{"issue":"6","key":"10.1016\/j.msard.2025.106932_bib0018","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/humrep\/deac041","article-title":"Women with female infertility seeking medically assisted reproduction are not at increased risk of developing multiple sclerosis","volume":"37","author":"Kopp","year":"2022","journal-title":"Hum. Reprod"},{"issue":"4","key":"10.1016\/j.msard.2025.106932_bib0019","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1474-4422(22)00426-4","article-title":"Family planning considerations in people with multiple sclerosis","volume":"22","author":"Krysko","year":"2023","journal-title":"Lancet. Neurol"},{"issue":"3","key":"10.1016\/j.msard.2025.106932_bib0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jamaneurol.2019.4173","article-title":"Association between breastfeeding and postpartum multiple sclerosis relapses: a systematic review and meta-analysis","volume":"77","author":"Krysko","year":"2020","journal-title":"JAMA. Neurol"},{"issue":"18","key":"10.1016\/j.msard.2025.106932_bib0021","doi-asserted-by":"crossref","first-page":"e1939","DOI":"10.1212\/WNL.0000000000009374","article-title":"Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort","volume":"94","author":"Langer-Gould","year":"2020","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.msard.2025.106932_bib0022","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1177\/13524585211002719","article-title":"Brain MRI activity during the year before pregnancy can predict post-partum clinical relapses","volume":"27","author":"Lehmann","year":"2021","journal-title":"Mult. Scler"},{"issue":"1","key":"10.1016\/j.msard.2025.106932_bib0023","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40120-021-00297-6","article-title":"Effects of pregnancy and breastfeeding on clinical outcomes and MRI measurements of women with multiple sclerosis: an exploratory real-world cohort study","volume":"11","author":"Lorefice","year":"2022","journal-title":"Neurol. Ther"},{"key":"10.1016\/j.msard.2025.106932_bib0024","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.msard.2017.12.016","article-title":"The evolution of \"No evidence of disease activity\" in multiple sclerosis","volume":"20","author":"Lu","year":"2018","journal-title":"Mult. Scler. Relat. Disord"},{"issue":"5","key":"10.1016\/j.msard.2025.106932_bib0025","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.1097\/AOG.0000000000002046","article-title":"Methods for estimating the due date","volume":"129","author":"Pettker","year":"2017","journal-title":"Obs. Gynecol"},{"key":"10.1016\/j.msard.2025.106932_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103389","article-title":"Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: differences between MS specialists and non-MS specialists","volume":"57","author":"Saposnik","year":"2022","journal-title":"Mult. Scler. Relat. Disord"},{"key":"10.1016\/j.msard.2025.106932_bib0027","article-title":"Pregnancy-induced changes in microRNA expression in multiple sclerosis","volume":"11","author":"Sondergaard","year":"2020","journal-title":"Front. Immunol"},{"key":"10.1016\/j.msard.2025.106932_bib0028","article-title":"Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy","author":"Thiel","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.msard.2025.106932_bib0029","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet. Neurol"},{"issue":"1","key":"10.1016\/j.msard.2025.106932_bib0030","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200349","article-title":"Pregnancy and infant outcomes in women with multiple sclerosis treated with Ocrelizumab","volume":"12","author":"Vukusic","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"issue":"1","key":"10.1016\/j.msard.2025.106932_bib0031","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/13524585221129472","article-title":"Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society","volume":"29","author":"Vukusic","year":"2023","journal-title":"Mult. Scler"},{"issue":"Pt 6","key":"10.1016\/j.msard.2025.106932_bib0032","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/brain\/awh152","article-title":"Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse","volume":"127","author":"Vukusic","year":"2004","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.msard.2025.106932_bib0033","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler"},{"key":"10.1016\/j.msard.2025.106932_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.907994","article-title":"Alterations of NK cell phenotype during pregnancy in multiple sclerosis","volume":"13","author":"Wisgalla","year":"2022","journal-title":"Front. Immunol"},{"issue":"6","key":"10.1016\/j.msard.2025.106932_bib0035","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200328","article-title":"Disease activity in pregnant and postpartum women with multiple sclerosis receiving Ocrelizumab or other Disease-modifying therapies","volume":"11","author":"Yeh","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"issue":"24","key":"10.1016\/j.msard.2025.106932_bib0036","doi-asserted-by":"crossref","first-page":"e2989","DOI":"10.1212\/WNL.0000000000012084","article-title":"Natalizumab, Fingolimod and dimethyl fumarate use and pregnancy-related relapse and disability in women with multiple sclerosis","volume":"96","author":"Yeh","year":"2021","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:47:56Z","timestamp":1781509676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825006704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":36,"alternative-id":["S2211034825006704"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106932","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relapse activity during pregnancy and the postpartum year is associated with accelerated disability progression in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106932"}}